BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Asieris Pharma Closes $15M B Round Financing

  The company will use the capital to support a China Phase III trial of APL-1202, a repurposed oral inhibitor of MetAP2.

  December 28, 2017

   · 

  1 min read
• 

  Business

  Merck Serono, WuXi AppTec and Pontifax Form Israeli Life Science Incubator

  The incubator will be located at Merck Serono’s current facilities in Yavne, a town in central Israel.

  December 28, 2017

   · 

  1 min read
• 

  Business

  Keryx, Norwich Pharma Mutually Terminate Manufacturing Agreement

  The deal was originally inked on Jan 17, 2014‍.

  December 28, 2017

   · 

  1 min read
• Drug Development

  Innovate Biopharmaceuticals’ Dose Response Data for Larazotide Acetate Demonstrating Its Unique Mechanism of Action and Applications in Diseases Caused by Increased Intestinal Permeability

  The data reveal a narrow dose response for larazotide with the higher doses showing inhibition.

  December 28, 2017

   · 

  3 min read
• Business

  Integrity Applications Signs Distribution Agreement for its GlucoTrack Non-Invasive Glucose Monitoring Device in the Netherlands

  The agreement became effective on December 22nd, 2017.

  December 28, 2017

   · 

  5 min read
• Business

  PetVivo Hires Randy Wenthold to Replace David Masters as Chief Technical Officer

  Mr. Wenthold has been involved with medical devices from a development, manufacturing, and division management role for over 25 years.

  December 28, 2017

   · 

  3 min read
• Pharm Country

  Tauriga Sciences to Diversify $25,000 of its Balance Sheet Cash into Groestlcoin and Gain Exposure to the Crypto Currency Sector

  This $25,000 aggregate purchase will be funded by the Company’s available cash and is expected to be completed over the next 90 days.

  December 28, 2017

   · 

  5 min read
• Business

  MDxHealth Announces Lowering of 2017 Guidance

  The next update will be provided on February 22, 2018 together with the full year financial results for 2017.

  December 28, 2017

   · 

  5 min read
• 

  Policy

  FDA Accepts GW Pharma’s Epidiolex NDA With Priority Review for Lennox-Gastaut Syndrome and Dravet Syndrome

  The PDUFA goal date for completion of the FDA review of the Epidiolex NDA is June 27, 2018.

  December 28, 2017

   · 

  6 min read
• 

  Drug Development

  Odonate Therapeutics Announces Initiation of CONTESSA, a Phase III Study of Tesetaxel in Patients with Locally Advanced or Metastatic Breast Cancer

  In patients with MBC, tesetaxel was shown to have robust single-agent antitumor activity in two, multicenter, Phase 2 studies.

  December 28, 2017

   · 

  7 min read